Top

Reactions Weekly

Published in:

01-06-2023 | Agranulocytosis | Case report

Methylprednisolone/propylthiouracil

Anti-neutrophil cytoplasmic antibody-positive vasculitis, agranulocytosis and lack of efficacy: case report

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Kang DH, et al. Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibody-Positive Vasculitis and Agranulocytosis: A Rare Case with Life-Threatening Multiple Systemic Manifestations. Endocrinology and Metabolism 38 : 282-284, No. 2, Apr 2023. Available from: URL: http://doi.org/10.3803/EnM.2022.1643

Title: Methylprednisolone/propylthiouracil
Anti-neutrophil cytoplasmic antibody-positive vasculitis, agranulocytosis and lack of efficacy: case report
Publication date: 01-06-2023
Publisher: Springer International Publishing
Keywords: Agranulocytosis
Vasculitis
Vasculitis
Hyperthyroidism
Propylthiouracil
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-41934-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Methylprednisolone/propylthiouracil

Anti-neutrophil cytoplasmic antibody-positive vasculitis, agranulocytosis and lack of efficacy: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Nivolumab

Metformin/valproate

Plasma

Antineoplastics/antiretrovirals/antivirals

Hydroxocobalamin

Immunosuppressants/inebilizumab/tozinameran